Summitry LLC’s Zoetis ZTS Stock Holding History

Summitry LLC’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-179,807	Closed	-$21.3M	–	379
2026 Q1	$21.3M	Buy	+179,807	New	+$22.2M	0.75%	52

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Summitry LLC's ZTS Position: Q2 2026 in Review

Summitry LLC sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 179,807 shares — an estimated $21.3M sold.

Summitry LLC first reported a position in ZTS in Q1 2026 and held it in 1 quarter. The position peaked at $21.3M in Q1 2026. 1,435 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

Summitry LLC reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
Summitry LLC sold 179,807 Zoetis shares in Q2 2026, an estimated $21.3M.
Summitry LLC first reported a position in Zoetis in Q1 2026 and held it in 1 quarter.
Summitry LLC's Zoetis position peaked at $21.3M in Q1 2026.
1,435 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.